We have analysed the P45L mutation in the cell cycle regulator cdk2 found through targeted genomic sequencing of a glioblastoma and affecting the PSTAIRE cyclin-binding helix characteristic of cdks. This evidence concerns the gene CDK2 and glioblastoma.